India trials of COVID-19 vaccine going on: Serum Institute

By: |
September 09, 2020 6:26 PM

The statement came after AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in the studies got sick.

"We can't comment much on the UK trials," Serum Institute India (SII) said in a statement adding "as far as Indian trials are concerned, it is continuing and we have faced no issues at all."“We can’t comment much on the UK trials,” Serum Institute India (SII) said in a statement adding “as far as Indian trials are concerned, it is continuing and we have faced no issues at all.” (Representative image)

Serum Institute of India on Wednesday said its trials of AstraZeneca’s COVID-19 vaccine candidate in the country were ongoing and had not faced any issues.

The statement came after AstraZeneca Plc stopped giving shots of its experimental coronavirus vaccine after a person participating in the studies got sick.

“We can’t comment much on the UK trials,” Serum Institute India (SII) said in a statement adding “as far as Indian trials are concerned, it is continuing and we have faced no issues at all.”

Serum Institute had entered into a manufacturing partnership with AstraZeneca to produce and supply 1 billion doses of the COVID-19 vaccine being developed by Oxford University.

The Indian firm is doing the clinical trials of AstraZeneca’s vaccine candidate in India.

Last month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct phase two and three human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.

The pause by AstraZeneca stemmed from a standard review of the company’s vaccine trials after one person developed an unexplained illness, the firm said in a statement.

The move was intended to give researchers time to examine safety data while maintaining the integrity of the trials, the British-Swedish company said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Nurse to doctor ratio in India estimated to be 1.7:1 on basis of NSSO data: Report
2Antibodies from original Covid virus strain don’t bind to variants: Study
3Growing need for Physician-centric solutions for the healthcare industry